Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Microorganisms
|
August 27, 2021
Simultaneous Removal of the Freshwater Bloom-Forming Cyanobacterium <i>Microcystis</i> and Cyanotoxin Microcystins via Combined Use of Algicidal Bacterial Filtrate and the Microcystin-Degrading Enzymatic Agent, MlrA
Suqin Wang, Siyu Yang, Jun Zuo, et al.
Environmental Microbiology
|
November 2, 2011
The role of microcystins in maintaining colonies of bloom-forming Microcystis spp
Nanqin Gan, Yan Xiao, Lin Zhu, et al.
Open Forum Infectious Diseases
|
February 19, 2026
Recovery and Stability of Omadacycline 150-mg Crushed Tablets Dispersed in Food or Water and Administered via Nasogastric Tube
Chenlin Hu, Ricky Huynh-Phan, Kevin M Rodriguez Robles, et al.
Applied Optics
|
August 5, 2014
Dwell-time algorithm for polishing large optics
Chunjin Wang, Wei Yang, Zhenzhong Wang, et al.
Antimicrobial Agents and Chemotherapy
|
January 17, 2025
Phase I trial comparing bile acid and short-chain fatty acid alterations in stool collected from human subjects treated with omadacycline or vancomycin
Jinhee Jo, Chenlin Hu, Thomas D Horvath, et al.
Antimicrobial Agents and Chemotherapy
|
July 21, 2022
Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection
Jacob McPherson, Chenlin Hu, Khurshida Begum, et al.
The Journal of Infectious Diseases
|
October 13, 2025
A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk
Hossaena Ayele, Jinhee Jo, Khurshida Begum, et al.
The Journal of Antimicrobial Chemotherapy
|
August 12, 2025
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial
Jinhee Jo, Travis J Carlson, Chenlin Hu, et al.
The Journal of Infectious Diseases
|
December 5, 2023
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers
Jinhee Jo, Chenlin Hu, Khurshida Begum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 8, 2022
Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial
Kevin W Garey, Jacob McPherson, An Q Dinh, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Microorganisms
|
August 27, 2021
Simultaneous Removal of the Freshwater Bloom-Forming Cyanobacterium <i>Microcystis</i> and Cyanotoxin Microcystins via Combined Use of Algicidal Bacterial Filtrate and the Microcystin-Degrading Enzymatic Agent, MlrA
Suqin Wang, Siyu Yang, Jun Zuo, et al.
Environmental Microbiology
|
November 2, 2011
The role of microcystins in maintaining colonies of bloom-forming Microcystis spp
Nanqin Gan, Yan Xiao, Lin Zhu, et al.
Open Forum Infectious Diseases
|
February 19, 2026
Recovery and Stability of Omadacycline 150-mg Crushed Tablets Dispersed in Food or Water and Administered via Nasogastric Tube
Chenlin Hu, Ricky Huynh-Phan, Kevin M Rodriguez Robles, et al.
Applied Optics
|
August 5, 2014
Dwell-time algorithm for polishing large optics
Chunjin Wang, Wei Yang, Zhenzhong Wang, et al.
Antimicrobial Agents and Chemotherapy
|
January 17, 2025
Phase I trial comparing bile acid and short-chain fatty acid alterations in stool collected from human subjects treated with omadacycline or vancomycin
Jinhee Jo, Chenlin Hu, Thomas D Horvath, et al.
Antimicrobial Agents and Chemotherapy
|
July 21, 2022
Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection
Jacob McPherson, Chenlin Hu, Khurshida Begum, et al.
The Journal of Infectious Diseases
|
October 13, 2025
A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk
Hossaena Ayele, Jinhee Jo, Khurshida Begum, et al.
The Journal of Antimicrobial Chemotherapy
|
August 12, 2025
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial
Jinhee Jo, Travis J Carlson, Chenlin Hu, et al.
The Journal of Infectious Diseases
|
December 5, 2023
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers
Jinhee Jo, Chenlin Hu, Khurshida Begum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 8, 2022
Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial
Kevin W Garey, Jacob McPherson, An Q Dinh, et al.
Page
of 4